🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an investigator-initiated study of safety, efficacy and tolerabilit...
Status
Completed
Location
Deaconess Clinic Gateway Health Center
Start Date
2009-07
Trial ID
NCT00939120
Treatments Being Tested
The purpose of the study is to assess the impact of treatment with tolterod...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2005-03
Trial ID
NCT00143481
Treatments Being Tested
This study is designed to evaluate the safety, tolerability, and efficacy o...
Status
Completed
Location
Coastal Clinical Research Inc.
Start Date
2018-06-14
Trial ID
NCT03583372
Treatments Being Tested
This study is designed to evaluate the safety, tolerability, and efficacy o...
Status
Completed
Location
Central Alabama Research
Start Date
2018-03-26
Trial ID
NCT03492281
Treatments Being Tested
The primary purpose of the trial is to show that tolterodine ER has no effe...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2006-12
Trial ID
NCT00411437
Treatments Being Tested
For many years, antimuscarinics have been first-line pharmacological treatm...
Status
Completed
Location
Samsung Medical Center
Start Date
2009-02
Trial ID
NCT00836381
Treatments Being Tested
Patients with overactive bladder are often treated with tolterodine, a medi...
Status
Completed
Location
Radiant Research, Inc.
Start Date
2011-05
Trial ID
NCT01302054
Treatments Being Tested
To compare the effect of tolterodine ER 4 mg to placebo on patient reported...
Status
Terminated
Location
Mytrus, Inc.
Start Date
2011-03
Trial ID
NCT01302938
Treatments Being Tested
The purpose of this study is to determine whether tamsulosin and tolterodin...
Status
Unknown
Location
Department of Urology, the First Affiliated Hospital of Chongqing Medical University
Start Date
2009-08
Trial ID
NCT00913315
Treatments Being Tested
This study will evaluate the pharmacologic effects of exposure to darifenac...
Status
Completed
Location
Investigative Site
Start Date
2006-11
Trial ID
NCT00413790
Treatments Being Tested